Northern Trust
ZYME icon

Northern Trust’s Zymeworks ZYME Stock Holding History

Northern Trust’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.39M Buy
321,073
+863
+0.3% +$21.9K ﹤0.01% 2308
2026
Q1 		$8.02M Buy
320,210
+12,231
+4% +$289K ﹤0.01% 2197
2025
Q4 		$8.11M Sell
307,979
-40,274
-12% -$878K ﹤0.01% 2188
2025
Q3 		$5.95M Sell
348,253
-1,546
-0.4% -$22.1K ﹤0.01% 2398
2025
Q2 		$4.39M Sell
349,799
-37,124
-10% -$442K ﹤0.01% 2531
2025
Q1 		$4.61M Sell
386,923
-7,907
-2% -$108K ﹤0.01% 2462
2024
Q4 		$5.78M Buy
394,830
+23,903
+6% +$334K ﹤0.01% 2422
2024
Q3 		$4.66M Buy
370,927
+6,513
+2% +$70.9K ﹤0.01% 2517
2024
Q2 		$3.1M Sell
364,414
-53,834
-13% -$479K ﹤0.01% 2660
2024
Q1 		$4.4M Buy
418,248
+1,102
+0.3% +$12.2K ﹤0.01% 2549
2023
Q4 		$4.33M Sell
417,146
-2,721
-0.6% -$21.7K ﹤0.01% 2582
2023
Q3 		$2.66M Sell
419,867
-1,161
-0.3% -$8.57K ﹤0.01% 2781
2023
Q2 		$3.64M Buy
421,028
+390,949
+1,300% +$3.5M ﹤0.01% 2678
2023
Q1 		$272K Buy
30,079
+17,247
+134% +$150K ﹤0.01% 3716
2022
Q4 		$101K Sell
12,832
-1,403
-10% -$9.86K ﹤0.01% 4090
2022
Q3 		$88K Buy
14,235
+2,120
+17% +$12.8K ﹤0.01% 4152
2022
Q2 		$64K Sell
12,115
-33,685
-74% -$204K ﹤0.01% 4335
2022
Q1 		$300K Sell
45,800
-634
-1% -$5.65K ﹤0.01% 3947
2021
Q4 		$762K Sell
46,434
-50
-0.1% -$1.04K ﹤0.01% 3643
2021
Q3 		$1.35M Sell
46,484
-199,723
-81% -$6.64M ﹤0.01% 3444
2021
Q2 		$8.54M Buy
246,207
+205,639
+507% +$6.52M ﹤0.01% 2480
2021
Q1 		$1.28M Sell
40,568
-8,981
-18% -$365K ﹤0.01% 3483
2020
Q4 		$2.34M Sell
49,549
-2,544
-5% -$118K ﹤0.01% 3121
2020
Q3 		$2.43M Buy
52,093
+784
+2% +$26.9K ﹤0.01% 2966
2020
Q2 		$1.85M Buy
51,309
+41,391
+417% +$1.52M ﹤0.01% 3078
2020
Q1 		$352K Buy
9,918
+159
+2% +$6.51K ﹤0.01% 3537
2019
Q4 		$444K Buy
+9,759
New +$355K ﹤0.01% 3585

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Northern Trust's ZYME Position: Q2 2026 in Review

Northern Trust increased its Zymeworks (ZYME) stake by 0.27% in Q2 2026, buying an estimated $21.9K and bringing the position to 321,073 shares worth $8.39M. The position accounts for ﹤0.01% of the portfolio, ranked #2308.

Northern Trust first reported a position in ZYME in Q4 2019 and has held it in 27 quarters since. The position peaked at $8.54M in Q2 2021. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Northern Trust held 321,073 shares of Zymeworks worth $8.39M as of Q2 2026.
  • Northern Trust bought 863 Zymeworks shares in Q2 2026, an estimated $21.9K.
  • Zymeworks made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2308 holding.
  • Northern Trust first reported a position in Zymeworks in Q4 2019 and has held it in 27 quarters since.
  • Northern Trust's Zymeworks position peaked at $8.54M in Q2 2021.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.